Truist Financial raised its target price and gave a 'buy' rating for CVS Health.
1 report, 1 independent
Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial raised its target price and gave a 'buy' rating for CVS Health.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CVS Health
company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
- Financial institutions including Truist Financial, Royal Bank of Canada, and Renaissance Technologies issued rating updates and reported institutional holdings changes to the SEC.
- RBC and Truist Financial issued rating updates and price targets for LINE.
- Truist Financial boosted price target and gave buy rating, and TD Cowen lifted target price and gave buy rating for Encompass Health.
- Deere & Company received mixed analyst ratings from Truist Financial and Bank of America on August 17, 2026.